Novartis rejects suggestion of supplying chemicals to Syria

By Vassia Barba

- Last updated on GMT

(Image: Getty/MadamLead)
(Image: Getty/MadamLead)

Related tags Novartis

Novartis says it did not export substances potentially used as chemical weapons to Syria, distancing itself from Brenntag exports.

The Swiss pharmaceutical company reportedly has a contract manufacturing and distribution deal with Mediterranean Pharmaceutical Industries (MPI), a Syrian drug manufacturer.

A report​ published on Tuesday revealed that Brenntag, a German chemicals wholesaler exported isopropanol and diethylamine for MPI via its Swiss subsidiary, Brenntag Schweizerhall, in 2014.

Brenntag, which saw its shares fall by 6% ​after the report was published, confirmed​ that isopropanol and diethylamine were delivered to Syria via its subsidiary, although "in accordance with applicable law​" and "according to the specification of a well-known Swiss pharmaceutical manufacturer".

Asked about its potential involvement in the exports, Novartis provided a statement that it supplied MPI with “only the active pharmaceutical ingredients (APIs) in compliance with applicable sanction laws”​, with the APIs supplied to ‘oncology and pharmaceutical innovation medicines units’ in the local market.

The company further noted that MPI had to obtain chemicals, such as isopropanol or diethylamine, from a third-party supplier. Isopropanol and diethylamine can be used for pharmaceutical manufacturing, but also for the production of chemical weapons and nerve agents such as VX and sarin gas, which were used by the Assad regime during the Syrian Civil War.

After several reports of NGOs regarding the use of chemical weapons in Syria, the EU placed restrictions on exporting raw materials used to make chemical weapons. Those restrictions also apply for indirect exports through Switzerland.

“In May 2018, we were asked by the Swiss State Secretariat for Economic Affairs (SECO)​ whether Novartis could be of assistance in obtaining the manufacturing documents from MPI showing that the isopropanol had been used to produce Voltaren Emulgel. Our only role was in the spirit of offering our good services to act as intermediary and to pass on the obtained documents from MPI to SECO for their assessment,”​ the statement continued.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us